Company intelligence / Profile preview
Immuno Cure BioTech Limited
Shatin, -, Hong Kong
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Immuno Cure BioTech Limited is a clinical-stage biotechnology company based in Hong Kong Science Park. It develops innovative immunotherapies using its proprietary PD‑1-enhanced DNA vaccine and Anti‑Δ42PD1 Antibody platforms. The company’s lead program, ICVAX—a therapeutic HIV DNA vaccine—has completed a Phase I trial in China with plans to advance to multi-center Phase II trials. Its anti‑Δ42PD1 antibody project targeting liver cancer was recently awarded significant government funding to progress from preclinical through Phase II trials. Additional pipeline assets target COVID‑19 and various solid tumors at early stages of development.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- DNA vaccinesMonoclonal antibodies (mAbs)Therapeutic vaccinesProphylactic vaccinesAutologous CAR-T (preclinical/early research)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Collaboration with the AIDS Institute at the University of Hong Kong (HKU)InnoHK’s Centre of Virology, Vaccinology and TherapeuticsGobi Partners GBA.
Beyond the preview
Go deeper on Immuno Cure BioTech Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immuno Cure BioTech Limited.